Clinical Trials Browser

Interventional × Hypertension × Endocrine × Clear all

Hypertension, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

NCT07470580 2026-03-13

ADERADHTA2

Phase NA Not yet recruiting

134 enrolled

Endocrine

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT03604198 2026-02-19

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Phase 2 Active not recruiting

125 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT01022515 2026-02-06

PHEO

Phase NA Completed

60 enrolled

CNSEndocrine

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT04530916 2025-11-17

WB2020

Phase 1/2 Active not recruiting

58 enrolled

Endocrine

Cardiovascular Diseases, Hypertension, Multiple Endocrine Neoplasia Type 1, Atherosclerosis

NCT03697109 2025-07-16

GRACE

Phase 3 Completed

152 enrolled 28 charts

Endocrine

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Pituitary ACTH Hypersecretion

NCT04373265 2024-02-23

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

Phase 1 Completed

15 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, Adrenocortical Hyperfunction, Cushing Syndrome, Diabetes Mellitus, Type 2, Endocrine System Diseases, Hyperglycemia, Hypertension, Pathologic Processes, Glucose Intolerance, Adrenocortical Carcinoma

NCT05839483 2023-07-17

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Phase NA Unknown

50 enrolled

Endocrine

ACTH Syndrome, Ectopic, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT02804750 2019-10-15

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Phase 2 Completed

35 enrolled 13 charts

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Phase 2 Terminated

4 enrolled 10 charts

EndocrineOther

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis

NCT01092078 2015-04-22

MISTER-B

Phase NA Completed

740 enrolled

EndocrineGastrointestinal

Colonic Neoplasms, Hypertension, Multiple Endocrine Neoplasia Type 1

Clinical Trials

Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma

ADERADHTA2

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

PHEO

WB2020

GRACE

Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Study to Evaluate CORT125134 in Participants With Cushing's Syndrome

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

MISTER-B